Volume 27, Number 12—December 2021
Research Letter
Postmortem Stability of SARS-CoV-2 in Mouse Lung Tissue
Table
Day | N gene copies, log10 | % Reduction of N gene copies† | TCID50/mL, log10 | % Reduction of TCID50/mL† | Lung inflammation score‡ |
SARS-CoV-2 N protein antigen score§ |
Positive for SARS N protein¶ |
---|---|---|---|---|---|---|---|
0 | 7.28 + 0.53 | NA | 5.48 + 0.44 | NA | 9.33 + 1.53 | 3.66 + 1.15 | 3 (100.0) |
1 | 6.39 + 1.59 | −48.85 + 48.14 | 4.54 + 1.48 | −50.88 + 58.82 | 7 + 2 | 2.66 + 2.31 | 2 (66.6) |
5# | 7.05 + 0.36 | −48.21 + 45.43 | 4.00 + 0.41 | −96.48 + 3.54 | 5.33 + 4.61 | 4 + 1.4 | 2 (100.0) |
14 | 5.53 + 1.43 | −82.95 + 29.13 | 2.78 + 1.21 | −99.35 + 0.86 | 10.33 + 1.53 | 1.66 + 2.88 | 1 (33.3) |
*Values are mean +SD, except as indicated. NA, not applicable; TCID50, 50% tissue culture infectious dose. †Compared with day 0. ‡Scale of 0–16, in which 16 represents most severe inflammation. §Scale of 0–5, in which 5 represents highest amount of antigen. ¶Values are no. (%). #Days 0,1, and 14 values reflect 3 mice. Day 5 values reflect 2 mice for histology and 3 mice for TCID50 and reverse transcription PCR.
Page created: September 21, 2021
Page updated: November 19, 2021
Page reviewed: November 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.